lystn

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit: https://www.naceonline.com/courses/putting-evolving-data-into-practice-in-copd-care

Featuring speaker Fernando Martinez, MD, MS, moderated by Gregg Sherman, MD

Summary

COPD is a common disease that is characterized by persistent respiratory symptoms and airflow limitation due to airway and/or alveolar abnormalities. Approximately 16 million people in the United States are diagnosed with COPD, and many more remain undiagnosed. The disease is the fourth leading cause of death in the United States. COPD should be considered in patients who have dyspnea, chronic cough or sputum production, and/or a history of exposure to risk factors for the disease. Evolving case-finding approaches seek to identify undiagnosed patients who would benefit from treatment. Once diagnosed with diagnostic classification guides personalization of COPD therapy, taking into account exacerbations and comorbidities, as well. In this activity, Dr. Martinez will discuss with the moderator case-finding, diagnosis, and approaches to treatment, giving time to answer common questions on these topics.

This podcast was recorded and is being used with the permission of the presenters.

Learning Objectives

Upon completion of this activity, learners should be able to:

• Utilize evolving approaches to case-finding and spirometry to ensure early diagnosis of COPD
• Employ current and emerging therapeutic strategies to ensure guideline-based management of COPD

This activity is accredited for CME/CE Credit.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit: https://www.naceonline.com/courses/putting-evolving-data-into-practice-in-copd-care

The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0 hours of pharmacology).

This activity is supported by an independent educational grant from AstraZeneca Pharmaceuticals